Highview Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.66M | Buy |
5,985
+68
| +1% | +$30.3K | 1.03% | 27 |
|
|
2025
Q1 | $2.87M | Buy |
5,917
+146
| +3% | +$70.8K | 1.2% | 26 |
|
|
2024
Q4 | $2.32M | Buy |
5,771
+102
| +2% | +$41.1K | 0.89% | 32 |
|
|
2024
Q3 | $2.64M | Buy |
5,669
+134
| +2% | +$62.3K | 1.07% | 27 |
|
|
2024
Q2 | $2.59M | Buy |
5,535
+110
| +2% | +$51.6K | 1.08% | 26 |
|
|
2024
Q1 | $2.27M | Buy |
5,425
+346
| +7% | +$145K | 1.02% | 26 |
|
|
2023
Q4 | $2.07M | Buy |
5,079
+121
| +2% | +$49.2K | 1.1% | 23 |
|
|
2023
Q3 | $1.72M | Sell |
4,958
-7
| -0.1% | -$2.43K | 0.99% | 26 |
|
|
2023
Q2 | $1.75M | Buy |
4,965
+239
| +5% | +$84.1K | 0.94% | 28 |
|
|
2023
Q1 | $1.49M | Buy |
4,726
+26
| +0.6% | +$8.19K | 0.86% | 30 |
|
|
2022
Q4 | $1.36M | Buy |
4,700
+54
| +1% | +$15.6K | 0.83% | 29 |
|
|
2022
Q3 | $1.35M | Buy |
+4,646
| New | +$1.35M | 1% | 25 |
|